Loening-Baucke V
Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City 52242.
J Pediatr. 1990 Feb;116(2):214-22. doi: 10.1016/s0022-3476(05)82877-x.
To determine whether outcome in chronically constipated and encopretic children with abnormal defecation dynamics could be improved with biofeedback training, we randomly assigned patients, 5 to 16 years of age, to receive conventional treatment alone (n = 19) or conventional plus biofeedback treatment (n = 22) and evaluated physiologic outcome at 7 months and clinical outcome at 7 and 12 months. Eighty-six percent of patients learned normal defecation dynamics with up to six biofeedback sessions. At 7 months, 13% of conventionally treated and 77% of biofeedback-treated patients had normal defecation dynamics (p less than 0.01); one conventionally treated (5%) and 12 biofeedback-treated patients (55%) had recovered (p less than 0.01). Learning normal defecation dynamics was correlated with clinical recovery (p less than 0.01). At 7 months, 11% of patients with normal defecation dynamics after biofeedback treatment had abnormal defecation dynamics, and 71% of the biofeedback-treated patients with normal defecation dynamics recovered. At 12 months, 16% of conventionally treated and 50% of biofeedback-treated patients had recovered (p less than 0.05). Balloon defecation did not improve significantly in those who learned normal defecation dynamics. Therefore the ability to defecate balloons is apparently not dependent on the normal function of the external and sphincter and pelvic floor muscles alone. Biofeedback treatment is complementary to a good conventional therapeutic regimen in patients with abnormal defecation dynamics.
为了确定生物反馈训练能否改善慢性便秘和大便失禁且排便动力学异常的儿童的治疗效果,我们将5至16岁的患者随机分组,一组仅接受常规治疗(n = 19),另一组接受常规治疗加生物反馈治疗(n = 22),并在7个月时评估生理指标,在7个月和12个月时评估临床指标。86%的患者通过最多6次生物反馈训练学会了正常的排便动力学。在7个月时,接受常规治疗的患者中有13%、接受生物反馈治疗的患者中有77%具有正常的排便动力学(p < 0.01);接受常规治疗的患者中有1例(5%)、接受生物反馈治疗的患者中有12例(55%)康复(p < 0.01)。学会正常的排便动力学与临床康复相关(p < 0.01)。在7个月时,生物反馈治疗后排便动力学正常的患者中有11%排便动力学异常,而排便动力学正常的接受生物反馈治疗的患者中有71%康复。在12个月时,接受常规治疗的患者中有16%、接受生物反馈治疗的患者中有50%康复(p < 0.05)。学会正常排便动力学的患者,气囊排便情况未显著改善。因此,气囊排便能力显然并非仅取决于外括约肌和盆底肌肉的正常功能。对于排便动力学异常的患者,生物反馈治疗是对良好常规治疗方案的补充。